Skip to content

Clinical trials

Stomach Neoplasms trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stomach Neoplasms Country / region: Taiwan Clear all

139 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20044
20054
20064
20075
20085
20094
20102
20115
20126
20135
20145
20153
20167
201710
20188
20199
20209
20219
202212
20238
20245
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed65
Recruiting22
Active, not recruiting17
Unknown status17
Terminated16
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Taiwan University Hospital17
AstraZeneca10
Hoffmann-La Roche7
Amgen6
Merck Sharp & Dohme LLC5
Ono Pharmaceutical Co., Ltd.5
Pfizer5
Eli Lilly and Company4
Novartis Pharmaceuticals4
AbbVie3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stomach Neoplasms139
Esophageal Neoplasms19
Neoplasms19
Carcinoma, Non-Small-Cell Lung17
Colorectal Neoplasms14
Ovarian Neoplasms13
Adenocarcinoma12
Breast Neoplasms12
Pancreatic Neoplasms12
Squamous Cell Carcinoma of Head and Neck12

Trials

Showing 1 to 25 of 139. Each trial links to its page on Pharma Observatory.

39 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.